Despite the typical stigma of retracting a scientific paper, Nathan Georgette is doing just fine — serving as a model to those many decades his senior.

Mick Mulvaney suggested Zika science is uncertain, so we shouldn’t bother to fund it.

Rush Holt, former Congressman, physicist and CEO of the American Association for the Advancement of Science (AAAS), explains how scientists should move forward under the Trump Administration.

Political compromise settles immigration row that could have severed Swiss–EU research agreements.

Information graphics and the fight for science in Trump’s America

Poor experimental design and statistical analysis could contribute to widespread problems in reproducing preclinical animal experiments.

Having a science-minded voice in the new president’s ear could potentially mediate some of Trump’s anti-science attitudes.

McGill's Neurological Institute open science agenda includes open access publication of all research data and findings, and an end to the practice of patenting the university's findings.

Recommendation engine Instrumentl aims to speed grant searching.

Ten people who mattered this year.

The Swiss parliament approved a law to limit immigration by giving its residents priority access to employment vacancies, in an effort to shore up ties with the EU.

Science policy is slowly waking up to the realisation that the value of science may lie in people and places rather than papers and patents.

Over 60 major German research institutions are canceling their subscriptions to all of Elsevier's academic and scientific journals, effective January 1, 2017.